Rivaroxaban and Ventricular tachycardia - a phase IV clinical study of FDA data
Summary:
Ventricular tachycardia is reported as a side effect among people who take Rivaroxaban (rivaroxaban), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Furosemide, and have Atrial fibrillation/flutter.
The phase IV clinical study analyzes which people have Ventricular tachycardia when taking Rivaroxaban. It is created by eHealthMe based on reports of 26,430 people who have side effects when taking Rivaroxaban from the FDA, and is updated regularly.
What is Rivaroxaban?
Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,544 Rivaroxaban users. Check the latest studies of Rivaroxaban.
What is Ventricular tachycardia?
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,282 drugs and 2,098 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
26,430 people reported to have side effects when taking Rivaroxaban.
Among them, 73 people (0.28%) have Ventricular tachycardia.

Among these 73 people:
How long have people been on Rivaroxaban when they have Ventricular tachycardia? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Ventricular tachycardia when taking Rivaroxaban? *
- female: 28.33 %
- male: 71.67 %
What is the age of people who have Ventricular tachycardia when taking Rivaroxaban? *
- 0-1: 0.0 %
- 2-9: 1.54 %
- 10-19: 0.0 %
- 20-29: 1.54 %
- 30-39: 1.54 %
- 40-49: 10.77 %
- 50-59: 13.85 %
- 60+: 70.77 %
What are other drugs people take besides Rivaroxaban? *
- Pantoprazole: 15 people, 20.55%
- Furosemide: 15 people, 20.55%
- Aspirin: 10 people, 13.70%
- Clopidogrel: 10 people, 13.70%
- Entresto: 9 people, 12.33%
- Hydrocodone: 8 people, 10.96%
- Cyclophosphamide: 7 people, 9.59%
- Metformin: 7 people, 9.59%
- Prednisone: 7 people, 9.59%
- Torsemide: 6 people, 8.22%
What are other side effects people have besides Ventricular tachycardia? *
- Cardiac Arrest: 15 people, 20.55%
- Overdose: 14 people, 19.18%
- Bradycardia (abnormally slow heart action): 13 people, 17.81%
- Breathing - Slowed Or Stopped: 9 people, 12.33%
- White Blood Cell Count Increased: 9 people, 12.33%
- Atrioventricular Block Complete (heart block complete): 9 people, 12.33%
- Electrocardiogram Qrs Complex Prolonged: 9 people, 12.33%
- Drug Level Increased: 8 people, 10.96%
- Atrioventricular Block Second Degree (heart block second degree): 8 people, 10.96%
- Electrocardiogram Pr Prolongation: 8 people, 10.96%
What are the existing conditions these people have? *
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 21 people, 28.77%
- High Blood Pressure: 10 people, 13.70%
- Cardiac Failure: 8 people, 10.96%
- Dyslipidaemia (abnormal amount of lipids): 8 people, 10.96%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 8.22%
- Nausea (feeling of having an urge to vomit): 4 people, 5.48%
- Nausea And Vomiting: 4 people, 5.48%
- Heart Rate Increased: 3 people, 4.11%
- Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 3 people, 4.11%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 4.11%
* Approximation only. Some reports may have incomplete information.
Do you take Rivaroxaban and have Ventricular tachycardia?
- Check whether Ventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rivaroxaban:
- Rivaroxaban (26,544 reports)
Ventricular tachycardia treatments and more:
- Ventricular tachycardia (26,755 reports)
How severe was Ventricular tachycardia and when was it recovered:
Expand to all the drugs that have ingredients of rivaroxaban:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rivaroxaban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Ventricular tachycardia:
- Ventricular tachycardia (1,282 drugs)
Browse all the conditions that are associated with Ventricular tachycardia:
- Ventricular tachycardia (2,098 conditions)
Related publications that referenced our studies
- Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
- Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Rivaroxaban) and Rivaroxaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sertraline Hydrochloride cause Chronic Obstructive Pulmonary Disease? - now
- Could Diazepam cause Corneal Dystrophy? - a second ago
- Could Diazepam cause Cardiovascular Insufficiency? - 2 seconds ago
- Could Diazepam cause Consciousness Fluctuating? - 3 seconds ago
- Could Triazolam cause Night Sweats? - 8 seconds ago
- Could Triazolam cause Movement - Uncoordinated? - 11 seconds ago
- Could Fosrenol cause Depressed Level Of Consciousness? - 12 seconds ago
- Could Korlym cause Fall? - 13 seconds ago
- Adderall 12.5 vs. Nuvigil, side effect and effectiveness comparison - 14 seconds ago
- Nuvaring and Neck Pain for Women aged 20-29 - 16 seconds ago